ML Research Intern – BS/MS (Summer 2027)

Location
NYC, or SF Bay Area
Workplace
Hybrid
Employment
Internship

About this role

About the Team

Join a world-class team at the forefront of AI and biochemistry.

At Genesis Molecular AI, we’re a tight-knit team of proven deep learning researchers, software engineers, and drug discovery pioneers. Our shared mission is nothing short of revolutionary: to forge the next generation of AI foundation models that will unlock groundbreaking therapies for patients with severe diseases.

We don’t just apply machine learning to biology; we are conducting fundamental research at the intersection of machine learning, physics, and computational chemistry, pushing the boundaries of each field. You will work side-by-side with top multidisciplinary researchers to design and build generative foundation models at scale, having access to ample compute and large-scale simulations.

About the Role

This is an opportunity to operate as a full member of our research team for the duration of your internship. You will be paired with a mentor and get hands-on experience building and testing models at the forefront of generative AI. Your high-impact project will likely involve working with our foundation models and could touch on cutting-edge areas like diffusion models, large language models (LLMs), or reinforcement learning. We’re looking for exceptional students passionate about applying their technical skills to challenging research problems and contributing directly to our mission.

You Will:

  • Contribute to a high-impact research project by building models, running experiments, and analyzing results for a key scientific challenge in generative AI.

  • Turn research ideas into high-quality code, implementing and optimizing multi-modal models and algorithms from the latest literature.

  • Design and run experiments at scale to validate promising approaches and hypotheses.

  • Present your work and findings to the team, contributing to our collaborative research environment.

You Are:

  • Currently enrolled in a Bachelor's or Master's program in Computer Science, Machine Learning, or a related technical field.

  • A skilled and agile coder with a passion for writing clean, efficient, and reliable code.

  • A curious and tenacious problem-solver, excited to tackle complex technical challenges.

  • Eager to learn about the intersection of AI and biochemistry and the drug discovery process.

What we offer:

  • A high-impact project, not a toy problem. Your work is chosen to have a direct line of sight to advancing our core scientific platform.

  • Dedicated mentorship from a senior researcher or engineer on our team who will partner with you, guide your project, and champion your growth.

  • Deep immersion in a world-class team. You'll join our paper discussions, research talks, and social events, becoming a true member of the Genesis AI team. The team reads and discusses 1-2 ML or chemistry papers every week to stay on top of the field and inspire new ideas.

Past intern projects include:

  • Developing a post-training protocol to improve LLM reasoning for drug discovery tasks

  • Designing a more efficient co-folding model architecture

  • Building a vector embedding method to tractably search billions-scale molecule libraries

  • Optimizing reinforcement learning algorithms to improve state-of-the-art diffusion models

  • Inventing novel inference-time steering methods to enhance co-folding model performance in the hands of chemists

About Genesis Molecular AI

Genesis Molecular AI is pioneering foundation models for molecular AI to unlock a new era of drug design and development. Our generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis is backed by premier AI and life science investors, including a16z, NVIDIA, Rock Springs Capital, Menlo Ventures, T. Rowe Price, Fidelity, and Radical Ventures. Genesis has also signed category-leading AI-pharma deals, the most recent of which was a significant expansion with Incyte (see coverage in Forbes and GEN) with a total potential deal value of several billion dollars.

Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.

Apply to Genesis Molecular AI

Clera fills in Genesis Molecular AI's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About Genesis Molecular AI

Genesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.

The GEMS platform integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through cycles of AI-enabled discovery and optimization.
We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI platform collaborations across a range of therapeutic areas including Gilead (2024), and Incyte (2025).

Genesis has raised over $300M in funding from top AI, technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. To learn more about Genesis Molecular AI, or current employment opportunities, please visit our website.

Team size
51-200 employees people
Industry
Biotechnology Research
Workplace
Hybrid
Locations
United States